Icosapent ethyl 1000 MG Oral Capsule — RxCUI 1304979
RxNorm drug concept · Semantic clinical drug
RxCUI 1304979
Semantic clinical drug · SCD
● Current RxNorm concept 34 FDA products
47 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1304979
Official nameIcosapent ethyl 1000 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asicosapent ethyl 1 GM Oral Capsule
FDA products mapped34
Package NDCs mapped47
Reported Medicaid activity (SDUD)187,804 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Icosapent Ethyl: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Icosapent ethyl is a highly purified omega-3 fatty acid that helps lower very high triglyceride levels in your blood. Depending on the specific product and your health situation, y...
- What exactly does icosapent ethyl do, and why has my doctor prescribed it?
- Take them twice a day with food — that's how they were used in all the clinical studies, and food helps your body absorb the medicine properly. Swallow the capsules whole every tim...
- How should I take my icosapent ethyl capsules?
🕸️ Concept Web — How Icosapent ethyl 1000 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Icosapent ethyl 1000 MG Oral Capsule
RxCUI 1304979 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Icosapent ethyl
1304974IN
-
Icosapent ethyl
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vascepa
1304980BN
-
Vascepa
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Icosapent ethyl Oral Capsule
1304978SCDF -
Icosapent ethyl Oral Product
1304976SCDG -
Icosapent ethyl Pill
1304977SCDG -
Icosapent ethyl Oral Capsule [Vascepa]
1304982SBDF -
Vascepa Oral Product
1304983SBDG -
Vascepa Pill
1304984SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Icosapent ethyl Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Icosapent ethyl 1000 MG
1304975SCDC -
Icosapent ethyl 1000 MG Oral Capsule [Vascepa]
1304985SBD -
Icosapent ethyl 1000 MG [Vascepa]
1304981SBDC
-
Icosapent ethyl 1000 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Icosapent ethyl 1000 MG
SCDC · 1304975 -
Icosapent ethyl Oral Capsule
SCDF · 1304978 -
Icosapent ethyl Oral Product
SCDG · 1304976 -
Icosapent ethyl Pill
SCDG · 1304977
Brand-Name Concepts
-
Icosapent ethyl 1000 MG Oral Capsule [Vascepa]
SBD · 1304985 -
Icosapent ethyl 1000 MG [Vascepa]
SBDC · 1304981 -
Icosapent ethyl Oral Capsule [Vascepa]
SBDF · 1304982 -
Vascepa Oral Product
SBDG · 1304983 -
Vascepa Pill
SBDG · 1304984 -
Vascepa
BN · 1304980
📦 FDA Products & Package NDCs
34 products · 47 package NDCs
47 package NDCs map to RxCUI 1304979 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00480-0126-49 | 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (0480-0126-49) | Icosapent Ethyl | Teva Pharmaceuticals, Inc. | 2022-09-09 |
| 00480-0127-89 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (0480-0127-89) | Icosapent Ethyl | Teva Pharmaceuticals, Inc. | 2022-12-15 |
| 13668-0761-12 | 120 g in 1 BOTTLE (13668-761-12) | Icosapent Ethyl | Torrent Pharmaceuticals Limited | 2026-04-22 |
| 16714-0636-01 | 120 CAPSULE in 1 BOTTLE (16714-636-01) | ICOSAPENT ETHYL | Northstar Rx LLC | 2025-07-01 |
| 31722-0298-24 | 240 CAPSULE in 1 BOTTLE (31722-298-24) | ICOSAPENT ETHYL | Camber Pharmaceuticals, Inc. | 2024-02-16 |
| 31722-0299-12 | 120 CAPSULE in 1 BOTTLE (31722-299-12) | ICOSAPENT ETHYL | Camber Pharmaceuticals, Inc. | 2024-02-16 |
| 42291-0046-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (42291-046-12) | Icosapent Ethyl | AvKARE | 2023-12-05 |
| 42806-0559-24 | 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (42806-559-24) | ICOSAPENT ETHYL | EPIC PHARMA, LLC | 2023-12-22 |
| 42806-0560-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (42806-560-12) | ICOSAPENT ETHYL | EPIC PHARMA, LLC | 2023-12-22 |
| 42806-0576-12 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (42806-576-12) | ICOSAPENT ETHYL | EPIC PHARMA, LLC | 2026-05-27 |
| 43598-0267-04 | 120 CAPSULE in 1 BOTTLE (43598-267-04) | Icosapent | Dr. Reddy's Laboratories, Inc. | 2021-06-21 |
| 52937-0001-20 | 120 CAPSULE in 1 BOTTLE (52937-001-20) | Vascepa | Amarin Pharma Inc. | 2012-10-01 |
| 52937-0003-16 | 1 BLISTER PACK in 1 CARTON (52937-003-16) / 16 CAPSULE in 1... | Vascepa | Amarin Pharma Inc. | 2016-09-16 |
| 52937-0003-40 | 240 CAPSULE in 1 BOTTLE (52937-003-40) | Vascepa | Amarin Pharma Inc. | 2016-09-16 |
| 52937-0005-20 | 120 CAPSULE in 1 BOTTLE (52937-005-20) | Vascepa | Amarin Pharma Inc. | 2025-12-05 |
| 52937-0101-08 | 1 BLISTER PACK in 1 CARTON (52937-101-08) / 8 CAPSULE in 1... | Vascepa | Amarin Pharma Inc. | 2012-10-01 |
| 59651-0812-08 | 120 CAPSULE in 1 BOTTLE (59651-812-08) | Icosapent ethyl | Aurobindo Pharma Limited | 2026-06-24 |
| 60429-0005-12 | 120 CAPSULE in 1 BOTTLE (60429-005-12) | Icosapent Ethyl | Golden State Medical Supply, Inc. | 2025-03-31 |
| 60505-4033-01 | 120 CAPSULE in 1 BOTTLE (60505-4033-1) | Icosapent Ethyl | Apotex Corp | 2021-12-16 |
| 60687-0764-21 | 30 BLISTER PACK in 1 CARTON (60687-764-21) / 1 CAPSULE in 1... | Icosapent Ethyl | American Health Packaging | 2024-02-21 |
| 63629-8247-01 | 30 CAPSULE in 1 BOTTLE (63629-8247-1) | Vascepa | Bryant Ranch Prepack | 2026-04-07 |
| 63629-8247-02 | 60 CAPSULE in 1 BOTTLE (63629-8247-2) | Vascepa | Bryant Ranch Prepack | 2026-04-07 |
| 63629-8247-03 | 120 CAPSULE in 1 BOTTLE (63629-8247-3) | Vascepa | Bryant Ranch Prepack | 2026-04-07 |
| 63629-8247-04 | 90 CAPSULE in 1 BOTTLE (63629-8247-4) | Vascepa | Bryant Ranch Prepack | 2026-04-07 |
| 63629-9311-01 | 120 CAPSULE in 1 BOTTLE (63629-9311-1) | Icosapent Ethyl | Bryant Ranch Prepack | 2022-07-06 |
| 63629-9312-01 | 120 CAPSULE in 1 BOTTLE (63629-9312-1) | Icosapent | Bryant Ranch Prepack | 2022-07-06 |
| 67184-0582-01 | 120 CAPSULE in 1 BOTTLE (67184-0582-1) | Icosapent Ethyl | Qilu Pharmaceutical Co., Ltd. | 2025-01-01 |
| 69238-2597-07 | 240 CAPSULE in 1 BOTTLE (69238-2597-7) | Icosapent ethyl | Amneal Pharmaceuticals LLC | 2023-11-01 |
| 69238-2598-08 | 120 CAPSULE in 1 BOTTLE (69238-2598-8) | Icosapent ethyl | Amneal Pharmaceuticals LLC | 2023-11-01 |
| 69680-0186-92 | 120 CAPSULE in 1 BOTTLE (69680-186-92) | Icosapent Ethyl | Vitruvias Therapeutics, Inc. | 2025-10-20 |
| 71335-2842-01 | 120 CAPSULE in 1 BOTTLE (71335-2842-1) | Icosapent Ethyl | Bryant Ranch Prepack | 2025-10-21 |
| 71335-2989-01 | 30 CAPSULE in 1 BOTTLE (71335-2989-1) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2989-02 | 60 CAPSULE in 1 BOTTLE (71335-2989-2) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2989-03 | 120 CAPSULE in 1 BOTTLE (71335-2989-3) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2989-04 | 90 CAPSULE in 1 BOTTLE (71335-2989-4) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-02-04 |
| 71335-3072-01 | 30 CAPSULE in 1 BOTTLE (71335-3072-1) | Icosapent Ethyl | Bryant Ranch Prepack | 2026-02-09 |
| 71335-3072-02 | 60 CAPSULE in 1 BOTTLE (71335-3072-2) | Icosapent Ethyl | Bryant Ranch Prepack | 2026-02-09 |
| 71335-3072-03 | 120 CAPSULE in 1 BOTTLE (71335-3072-3) | Icosapent Ethyl | Bryant Ranch Prepack | 2026-02-09 |
| 71335-3072-04 | 90 CAPSULE in 1 BOTTLE (71335-3072-4) | Icosapent Ethyl | Bryant Ranch Prepack | 2026-02-09 |
| 71335-3148-01 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-3148-1) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-06-18 |
| 71335-3148-02 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-3148-2) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-06-18 |
| 71335-3148-03 | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-3148-3) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-06-18 |
| 71335-3148-04 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (71335-3148-4) | ICOSAPENT ETHYL | Bryant Ranch Prepack | 2026-06-18 |
| 72162-1000-02 | 120 CAPSULE in 1 BOTTLE (72162-1000-2) | Icosapent Ethyl | Bryant Ranch Prepack | 2024-12-24 |
| 72603-0129-01 | 120 CAPSULE in 1 BOTTLE (72603-129-01) | Icosapent Ethyl | Northstar Rx LLC | 2022-01-31 |
| 72865-0289-24 | 240 CAPSULE in 1 BOTTLE (72865-289-24) | ICOSAPENT ETHYL | XLCare Pharmaceuticals, Inc. | 2024-02-16 |
| 72865-0290-12 | 120 CAPSULE in 1 BOTTLE (72865-290-12) | ICOSAPENT ETHYL | XLCare Pharmaceuticals, Inc. | 2024-02-16 |
Observed labelers:
Bryant Ranch Prepack (20) ·
Amarin Pharma Inc. (5) ·
EPIC PHARMA, LLC (3) ·
Amneal Pharmaceuticals LLC (2) ·
Camber Pharmaceuticals, Inc. (2) ·
Northstar Rx LLC (2)
· +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.